Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report.

Serena Vita Alessandra D'Abramo Andrea Coppola Chiara Farroni Anna Paola Iori Francesca Faraglia Alessandro Sette Alba Grifoni Cecilia Lindestam Arlehamn Michele Bibas Delia Goletti Emanuele Nicastri

Front Oncol

Clinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

Published: February 2024

Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10896944	PMC
http://dx.doi.org/10.3389/fonc.2024.1290614	DOI Listing

Publication Analysis

Top Keywords

hematopoietic stem

stem cell

cell transplantation

sars-cov-2 infection

combined antiviral

antiviral therapy

therapy effective

effective feasible

feasible option

option allogenic

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!